People with rare diseases, like sickle cell disease, have unique and complex challenges and the Pfizer partnership provides an opportunity for NNPA to inform and educate readers of Black-owned newspapers in more than 70 markets across the country on sickle cell disease, which NNPA President and CEO Dr. Benjamin F. Chavis, Jr., said is an often misunderstood disease that has a profound impact on the health and well-being of those affected.
Browsing: Health
The team has received a $26 million grant as part of former Vice President Joe Biden’s Cancer Moonshot Initiative to conduct the largest study ever to look at the underlying factors and reasons that put African American men at higher risk for developing and dying from prostate cancer.
Ben Crump hosted a press conference in Atlanta on Monday, February 25, 2019, in partnership with Attorney R. Allen Smith and Janice L. Mathis, Esq., executive director of National Council of Negro Women (NCNW), the oldest advocacy group for minority women, to alert women of color about evidence that shows a direct correlation between ovarian cancer and the use of Johnson & Johnson baby powder.
David Casey, the vice president of Workforce Strategies and Chief Diversity Officer at CVS Health, joined other CVS Health representatives at Jesse Jackson’s Rainbow Push 22nd Annual Wall Street Project Economic Summit in New York where, among other things, care providers demonstrated the company’s pop-up health screenings – known as Project Health.
African American women are twice as likely as Caucasian women to be diagnosed with invasive cervical cancer and 2-3 times more likely to die from this diagnosis. Before we examine why this health disparity exists, let’s explore the historical gains that lead to the reduction of invasive cervical cancer diagnosis and deaths.
Women, especially women of color and poor women, tend to suffer disproportionately in our healthcare system. The problem is growing worse now that there’s a group of trial lawyers eager to exploit female victims, under the guise of offering help.
Vivacelle Bio, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1. VBI-1 is a paradigm-changing cardiovascular support fluid that is designed for the treatment of patients with emergently life-threatening conditions due to blood loss and other causes of severe hypovolemia (low blood volume).
Thirty years ago, a diagnosis of HIV or AIDS was a death sentence for many. As the years have gone by, though, advances have been made in the area of treatment and People Living With HIV (PLWH) are living longer
Study Name: Cognitive Training with and without tDCS to Improve Cognition in HIV
Positive Healthcare (PHC) today filed suit against the Florida Agency for Healthcare Administration (AHCA) to enjoin the agency from recklessly moving thousands of patients to a for-profit health plan. Thousands of vulnerable individuals living with HIV in Florida are at risk of losing the life-saving, sensitive care and services they need if AHCA’s actions are allowed to proceed